Concepedia

Edward F. McClay

EF

38

Publications

1.7K

Citations

25

H-Index

1987

Active since

Affiliations

University of California San Diego(Current)

California Cancer Associates for Research and Excellence

Merck (Germany)

Ono Pharmaceutical (United States)

Sarah Cannon

Edward F. McClay is an author at University of California San Diego specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

1987–2023

38

Publications

38

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

Julius Strauss, Margaret E. Gatti‐Mays, Byoung Chul Cho et al. · Journal for ImmunoTherapy of Cancer · 2020 · 153 citations · Full text

A Comparison of Intravenous versus Intraperitoneal Chemotherapy for the Initial Treatment of Ovarian Cancer

Saeeda Kirmani, Patricia S. Braly, Edward F. McClay et al. · Gynecologic Oncology · 1994 · 111 citations

, , +8

Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.

Edward F. McClay, Michael J. Mastrangelo, Robert E. Bellet et al. · PubMed · 1987 · 97 citations

, , +19

PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label single‐arm phase 2 study

Daniel P. Petrylak, Nicholas J. Vogelzang, Kamal Chatta et al. · The Prostate · 2019 · 82 citations

Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort

Byoung Chul Cho, Amaury Daste, Alain Ravaud et al. · Journal for ImmunoTherapy of Cancer · 2020 · 80 citations · Full text

Rows per page

1–5 of 38